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In vivo surface dosimetry with a scintillating fiber dosimeter in 
preclinical image-guided radiotherapy 
 
Abstract 
Purpose. New preclinical image-guided irradiators and treatment planning systems represent a huge 
progress in radiobiology. Nevertheless, quality control of preclinical treatments is not as advance as in 
clinical radiotherapy and in vivo dosimetry is little developed. In this study, we evaluate the use of a 
scintillating fiber dosimeter called DosiRat to verify the agreement between the doses planned with 
SmART-Plan and the measured doses during small animal irradiations. Methods. In vivo dosimetry was 
first evaluated with DosiRat through dose measurements performed at the surface of a 3  9  3 cm3 
phantom. Measured and planned doses were compared for different irradiation conditions (prescription 
point, anterior and posterior beams, 5 mm and 10 mm irradiation fields). In a second phase, measured 
and planned doses were compared for rat brain irradiations performed with anterior beams, with DosiRat 
positioned at the beam entrance. Comparisons were performed for different tube currents (1.3 and 
13 mA), collimations (5, 10 and 25 mm diameter) and planned doses (0.1, 0.5, 2 and 10 Gy). Results. 
In the case of the phantom irradiations, planned and measured doses showed discrepancies smaller than 
the 5 % accuracy of the TPS, except in cases in which the dosimeter was not centered in the irradiation 
field. The differences were larger for animal irradiations (from -3.3 % to 8.8 %) because of variations 
of the beam energy spectrum and the non-equivalence between materials at medium and low energy. 
Conclusions. This study highlighted the complexity to implement one-dimension in vivo dosimetry in 
orthovoltage millimetric beams. Nevertheless, DosiRat is well adapted to in vivo dosimetry because of 
its small volume and its direct reading and allowed in vivo control of planned doses for anterior beams 
down to 5 mm diameter.  
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1. Introduction 
The use of preclinical image-guided irradiators is rapidly spreading due to their strong similarities with 
clinical systems on a smaller scale.1 New systems such as the X-RAD 225Cx, now sold as the X-RAD 
SmART (Precision X-Ray, Inc., North Branford, CT, USA) and the Small Animal Radiation Research 
Platform (SARRP, Xstrahl Inc., Camberley, Surrey, UK) irradiators use dedicated treatment planning 
softwares (TPS) which provides more robust dosimetry and treatment panning accuracy for preclinical 
studies that quantify biological responses to ionizing radiations.2 Nevertheless, the quality control of 
preclinical treatments is not as advanced as in clinical practice3,4 and preclinical in vivo dosimetry is 
little developed5,6. In clinical radiotherapy, in vivo dosimetry verifies the agreement between planned 
and delivered doses, which allows the detection of systematic errors coming from various origins (beam 
dose calibration, accelerator instabilities, patient positioning...). Preclinical radiotherapy presents even 
more sources of error than clinical radiotherapy. The operation of the irradiator can lead to human error 
during the change of the external filtration between imaging and irradiation, or during the collimator 
selection. Misalignment of the beam or the stage can also occurs as well as animal motion during irra-
diation. All these events have a significant impact on dose accuracy and consequently on the interpreta-
tion of radiobiological results. An accurate control of delivered dose is thus of major importance to 
improve the reproducibility and reliability of preclinical investigations.  
Several teams carried out studies to answer the need of in vivo dosimetry. Kuess et al used thermolumi-
nescent dosimeters (TLD) inserted in the animal mouth during irradiation.7 They showed satisfying re-
sults, with measurements comparable to reference measurements performed in a phantom. Nevertheless, 
even if a careful calibration and handling of TLDs can provide an accuracy between 1 % and 3 %,8 their 
manipulation is quite difficult and their read-out is delayed. Ngwa et al used metal oxide semiconductor 
field effect transistors (MOSFET) dosimeters surgically implanted into animals to assess the effect of 
tissue heterogeneity on dose calculation for different anatomical locations.5 They reported that 
MOSFESTs can perform real-time measurements and could serve as fiducial markers. Nevertheless, 
they also pointed out the energy dependence and angular dependence of these detectors. Anvari et al 
utilized the electronic portal imaging device (EPID) on the SARRP for quality assurance measurements 
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with potential for usage in in vivo dosimetry. 6 Granton et al also studied this approach. They showed 
that the imaging panel could be used to verify the agreement between planned and delivered doses with 
a 5 % uncertainty for beams as small as 4 mm.9 
Other dosimeters adapted to millimeter beams and medium energy X-rays can be considered to perform 
small animal in vivo dosimetry. Among them, semiconductor diodes and diamond detectors have the 
advantage of their small size. Scintillating fiber dosimeters (SFD) are also good candidates to perform 
real time controls in preclinical dosimetry. Their sensitive volume is made of plastic scintillating fibers 
(usually polystyrene or polyvinyltoluene based) of small diameter (0.5 to 1 mm). SFDs have been ex-
tensively studied for dosimetry in clinical radiotherapy because of their water equivalence at high energy 
(MeV X-rays), their excellent reproducibility and response linearity with dose and dose rate.10,11 Their 
suitability for small field dosimetry has already been demonstrated in clinical radiotherapy12-14 and more 
recently in preclinical radiotherapy.15 Because of all these characteristics, PSDs are a very promising 
tool for in vivo dosimetry to control the delivered dose as well as potential misalignments between the 
target and the beam. We previously developed and evaluated a prototype named DosiRat, specifically 
adapted to preclinical millimeter and orthovoltage beams.16,17 This dosimeter showed a highly repeata-
ble, reproducible and linear response with dose and dose rate in treatment beams.9 It was also success-
fully used in preclinical relative dosimetry to measure percentage depth dose distributions in a 4  4 cm² 
irradiation field and to measure relative output factors at the surface of a phantom for irradiation fields 
as small as 2.5 mm diameter.10 In this study, we evaluate the ability of DosiRat to perform in vivo dose 
control during phantom and rat brain irradiations. Contrary to other preclinical studies where the objec-
tive was to assess the effect of tissue heterogeneity and composition on treatment plans,5,7 our main 
purpose is to verify that the delivered dose corresponds to the intended one and that it does not suffer 
from setup errors. Consequently, non-invasive surface measurements have been preferred. 
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2. Materials and methods 
The response of the scintillating fiber dosimeter for in vivo dosimetry was evaluated by comparing 
DosiRat measurements to planned doses in two configurations: a single beam irradiation on a rectangu-
lar polymethyl methacrylate (PMMA) phantom, which dimensions (3  9  3 cm3) are representative of 
animal size, and during rat brain irradiation. 
2.1. Image-guided preclinical irradiator 
This study was performed with the X-RAD 225Cx preclinical irradiator. This platform principally con-
sists of a 225 kVp X-ray tube mounted on a rotating C-arm, associated to a high resolution imaging 
panel (Perkin Elmer, Fremont, California, USA) and a precise positioning stage. The X-ray beam can 
be used either for imaging acquisitions or for treatment irradiations. Imaging acquisitions usually use 
tube voltages between 40 and 120 kVp and tube currents below 1 mA with an external filtration of 2 mm 
of aluminum. Two acquisition modes are supported by the system: a fluoroscopy mode, providing real 
time projections in two dimensions, and a Cone Beam Computed Tomography (CBCT) mode, providing 
3-dimensionnal reconstructions with voxel sizes of 100, 200 or 400 µm. Treatment irradiations generally 
use a tube voltage of 225 kVp and a tube current of 13 mA with an external filtration of 0.3 mm of 
copper. Various collimators can be used depending on the target volume. In this study, we worked with 
circular collimators of diameters ranging from 5 to 25 mm and a square collimator of 4  4 cm². 
2.1.1. Absolute dose rate. The irradiator absolute dose rate was measured at 225 kVp and 13 mA with 
a PTW 30013 ionization chamber calibrated in absorbed dose to water for various beam qualities. These 
calibrations are traceable to the standards of the German National Laboratory Physikalisch-Technische 
Bundesanstalt (PTB, Braunschweig, Germany) and were interpolated for our irradiator beam quality. 
According to the IAEA TRS-398 protocol for orthovoltage beams, the measurement was performed at 
isocenter (corresponding to a source-to-detector distance [SDD] of 30.7 cm) at a depth of 2 cm in a 
water tank of 30  30  30 cm3 positioned above the imaging panel on a customized mechanical support. 
The TRS-398 protocol was slightly modified by using a 4  4 cm² irradiation field instead of 
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10  10 cm², following preclinical practice.18 The average value of 3 ionization chamber readings (𝑀) 
was converted into absorbed dose to water (𝐷) following Eq. (1): 
 𝐷 = 𝑁𝑤  𝑘𝑄 𝑘𝑇𝑃 𝑘𝑖𝑜𝑛 𝑘𝑝𝑜𝑙  𝑀 (1) 
with 𝑁𝑤 the ionization chamber calibration factor and 𝑘𝑄 the beam quality correction factor interpolat-
ing the closest specified correction factors given by the calibration certificates. 𝑘𝑇𝑃, 𝑘𝑖𝑜𝑛 and 𝑘𝑝𝑜𝑙 are 
the temperature-pressure, ion collection efficiency and polarity correction factors respectively and have 
been experimentally determined. 
2.1.2. Ramp-up effect. The absolute dosimetry was performed with a beam stabilized in voltage and 
current. Nevertheless, a ramp-up time exists to reach the nominal tube voltage and current, during which 
the dose rate is lower than the stabilized one. This ramp-up time was measured in order to correct, if 
needed, the exposure time and avoid under-dose deposition. 
Air kerma was measured at the irradiator isocenter with the PTW 30013 ionization chamber calibrated 
in air kerma for two different tube currents: 1.3 and 13 mA. Measurements were performed for irradia-
tion times of 5, 10, 15, 30, 60, 120 and 180 seconds and the ramp-up time was deduced from the intercept 
of the air kerma as a function of irradiation time with the time-axis. 
2.2. Scintillating fiber dosimetry 
The dose measurements were performed with DosiRat scintillating fiber dosimeter, previously fully 
described by Le Deroff et al.16,17 In all this study, we used a BCF-12 (polystyrene based, Saint-Gobain 
Crystal, Paris, France) scintillating probe of 2 mm length and 1 mm diameter, presenting an effective 
measurement point at about 0.5 mm from its surface. DosiRat was calibrated in absorbed dose to water 
in a 4  4 cm² irradiation field at 225 kVp. It was placed at isocenter (SDD = 30.7 cm), at a depth of 2 
cm in a water tank, and irradiated at the reference dose rate (previously measured with the PTW 30013 
ionization chamber, see section 2.1.1) in order to determine a calibration factor in Gy/pC. 
Preclinical irradiation conditions are different from absolute dosimetry conditions, particularly in terms 
of beam size and scatter volume. They induce changes in the beam energy spectrum and variations of 
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plastic scintillating dosimeters energy response, primarily due to the non-equivalence of the absorption 
coefficient of polystyrene relative to water.15,17 As detailed in Le Deroff et al work, correction factors 
must be calculated by Monte Carlo simulations to take into account beam energy modifications between 
preclinical conditions and the calibration configuration.17 
The correction factors used in this work were calculated on PMMA phantom of 3 9 3 cm3, for dose 
measurements either at the beam entrance or at the beam exit with various collimator sizes (see table 
1). 
 
Table 1. DosiRat energy correction factors for dose measurement at the entrance or the exit of a 3 9 3cm3 
PMMA phantom, for a single anterior beam, with various collimator sizes. 
Measurement type 25 mm diameter collimator 10 mm diameter collimator 5 mm diameter collimator 
Entrance 0.984 0.973 0.969 
Exit 0.957 0.948 0.945 
 
In all this study, the adequate correction factor was applied to DosiRat measurement, depending on the 
configuration. 
2.3. Treatment planning 
Phantom and rat brain irradiations were planned with a dedicated small animal TPS, SmART-Plan 
(Small Animal RadioTherapyPlan), developed by the MAASTRO Clinic12 and commercialized by Pre-
cision X-Ray, Inc. (North Branford, CT, USA) for the X-RAD 225Cx irradiator. The software includes 
the different steps of a clinical treatment planning: the upload of a CBCT acquisition, the tissues seg-
mentation (chemical composition and density), the volumes of interest contouring and the definition of 
the ballistic and computation of the dose distribution. SmART-Plan is interfaced with the Monte Carlo 
(MC) program DOSXYZnrc19 to perform the dose computation. The dosimetric accuracy of the TPS 
has been assessed by the manufacturer for all the collimators through lateral and depth dose profiles and 
for complex irradiation plans performed in solid water. During this commissioning, computed dose dis-
tributions were compared to experimental distributions measured with radiochromic films (GafChromic 
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EBT3, Ahsland Specialty Ingredients, Wayne, NJ) and showed that for the large majority of dose meas-
urements, dosimetric agreement lied well within 5 % for collimators of 5 mm diameter or more. This 
accuracy has been confirmed by radiochromic films measurements performed at the surface of our 
PMMA phantom and presented in the supplementary data. 
The treatment planning of the phantom and rat brain irradiations performed in this work is illustrated in 
figure 1 and described below.  
 
 
Figure 1. Treatment planning with DosiRat positioned at the beam entrance in a 5 mm diameter beam. The phan-
tom irradiation is represented in the left side of the figure and the rat brain irradiation in the right side. In both 
cases, the 2 mm long scintillating volume is contoured in cyan and overwritten by water composition and density 
to correspond to the dose to water calibration. The 5 mm diameter irradiation beam is displayed in green in the 
“segmentation and contouring” step. The dose distribution produced by SmART-Plan was post-processed with 
ImageJ.21  
 
A CBCT acquisition was performed at 80 kVp, with a tube current of 1 mA, an external filtration of 
2 mm of aluminum and a spatial resolution of 200 µm in the three directions. The resulting acquisition 
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was uploaded in the SmART-Plan software where the CBCT voxels were converted into the appropriate 
materials: PMMA and air in the case of the phantom, soft tissue, bone and air in the case of the animal 
irradiation.20 As DosiRat was calibrated in dose to water (see section 2.2), the scintillator volume was 
contoured and overwritten by water composition and density. The treatment beams were defined and 
aimed at the target located in the rat brain. The dose distribution was then computed with 1 % statistical 
uncertainty, providing a dose map in DICOM format. The average dose to water in the scintillator vol-
ume was extracted from this dose map with the ImageJ analysis software.21 
2.4. Phantom irradiations 
Prior to animal experiments, the agreement between the planned and the delivered dose was evaluated 
with a PMMA phantom of animal size (3     cm3). CBCT acquisitions were used to accurately po-
sition DosiRat at the surface of the phantom. Two treatment configurations were planned following the 
steps described in section 2.3. 
In the first configuration, the prescription point was defined at the phantom surface in the scintillator 
volume (thus positioned at a SDD of 30.7 cm). An anterior or a posterior beam was planned to deliver 
1 or 2 Gy in the scintillator, with 5 and 10 mm diameter collimators. 
In the second configuration, the prescription point was placed at a depth of 1 cm below the dosimeter, 
to mimic the irradiation of a rat brain. An anterior or a posterior beam was planned with 5 and 10 mm 
diameter collimators to deliver 2 Gy at the prescription point. 
2.5. Rat brain irradiations 
Post mortem and in vivo irradiations of rat brain were planned following the procedure described in 
section 2.3. DosiRat was centered on each rat head prior to the treatment planning using either the po-
sitioning lasers (for the 25 mm diameter field irradiations as shown in figure 2) or a CBCT acquisition 
(for the 5 and 10 mm diameter irradiation fields experiments).  
Post mortem irradiations were performed on 3 rats. Doses of 0.1, 0.5 and 2 Gy were prescribed in the 
brain with anterior beams and 5 and 10 mm diameter collimators. Doses of 0.1 Gy were delivered with 
11 
 
a tube current of 1.3 mA to avoid too short irradiation times. For the doses of 0.5 Gy, two tube currents 
(1.3 and 13 mA) were tested. Each irradiation was reproduced three times, the animal and the dosimeter 
being repositioned between each measurement in order to evaluate the whole dosimetry process repro-
ducibility. 
 
 
Figure 2. Irradiation of a rat brain and dose measurement by DosiRat positioned at the beam entrance, using the 
positioning lasers. 
 
In vivo irradiations were performed on 6 rats. The animal investigations were performed under the cur-
rent European directive (2010/63/EU) in authorized laboratories (B14118001) and with the permission 
of the regional and national committees on animal ethics (CENOMEXA, APAFIS#00919). Animal care 
and monitoring during the experiments was insured by competent personnel for animal experimentation. 
Isoflurane anesthesia was used for all rats: 5 % for induction and 2.5% for maintenance in a gas mixture 
of 70% of nitrous oxide (N2O) and 30% of oxygen (O2). Rectal temperature was monitored and main-
tained around 37.0 °C throughout the experiments. A dose of 10 Gy was prescribed to 3 rats and a dose 
of 0.1 Gy (delivered with a tube current of 1.3 mA) to the 3 other rats. The irradiations were performed 
with an anterior beam and a collimator of 25 mm diameter. 
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Weight differences between post mortem and in vivo animals (about 400 and 600 g respectively) con-
tributed to diversify the configurations. 
3. Results 
3.1. Absolute dose rate and ramp-up 
A dose rate of 3.21 Gy/min was measured in the reference irradiation conditions (225 kVp, 13 mA), at 
isocenter at a depth of 2 cm in water, in a 4  4 cm² irradiation field. This measurement is consistent 
with Lindsay et al work on multi-institution commissioning of an X-RAD 225Cx.18 
The ramp-up effect of our irradiator was measured for tube currents of 1.3 and 13 mA. The air kerma is 
presented as a function of the irradiation time in figure 3. The curves show ramp-up times of 1.9 seconds 
at 1.3 mA and 2.3 seconds at 13 mA. These values are significant compared to typical irradiation times 
of approximately 40 seconds used to deliver 2 Gy, leading to an overestimation of the delivered dose by 
SmART-Plan. This bias was thus corrected in this entire study by subtracting the ramp-up time multi-
plied by the dose rate. The correction corresponds to 0.01 Gy at 1.3 mA and 0.12 Gy at 13 mA. 
 
 
Figure 3. Ramp-up time (t0) determination with air kerma measurement expressed as a function of the irradiation 
time for two tube currents (1.3 and 13 mA). The box figure is a zoomed in portion of the main figure up to 0.2 Gy 
and 6 s. 
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Additionally for the low dose-rate irradiations, the irradiator control panel indicated that the actual tube 
current reached by the tube was 1.335 mA instead of the nominal 1.3 mA. The corresponding planned 
doses were thus corrected to take into account this 2.7 % additional delivered dose. 
3.2. Phantom irradiations 
Table 2 presents the planned doses, the doses measured with DosiRat and the corresponding relative 
differences for the different irradiation configurations. 
 
Table 2. Comparison between the planned doses and the doses measured with DosiRat at the surface of the 
phantom for different treatment plans. The planned dose are corrected from the ramp-up time. 
Prescription 
point 
Beam diam-
eter (mm) 
Prescribed dose 
(Gy) 
Ballistic 
Planned dose in 
the dosimeter 
(Gy) 
Measured dose 
(Gy) 
Relative 
difference 
DosiRat 
10 mm 
2 anterior 1.89 1.97 4.0% 
1 anterior 0.89 0.91 2.5% 
1 posterior 0.89 0.90 1.0% 
5 mm 
2 anterior 1.89 1.96 3.4% 
1 anterior 0.90 0.91 1.7% 
1 posterior 0.89 0.93 3.4% 
 10 mm 2 anterior 2.77 2.87 3.5% 
Phantom at 2 posterior 1.60 1.61 0.5% 
1 cm depth 
5 mm 2 anterior 2.87 2.96 3.2% 
  2 posterior 1.56 1.28 -17.7% 
 
Discrepancies between planned and measured doses stay below 5%, except for the last measurement 
which corresponds to the irradiation of a target inside the phantom with a 5 mm diameter posterior beam. 
In this configuration, even though a Winston Lutz procedure was applied prior to irradiation, 22 the 
DosiRat sensitive volume was not entirely included in the irradiation field, leading to signal loss. 
Excluding this measurement, the average difference between planned and measured doses is 2.6 % with 
a standard deviation of 1.2 %. 
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Table 3. Comparison between the planned doses and the doses measured with DosiRat positioned on the rat 
head for different treatment plans. The planned doses are corrected from the ramp-up time and the tube current 
actual value. 
Tube  
curent 
Beam diam-
eter (mm) 
Prescribed 
dose to the 
brain (Gy) 
Planned dose in 
the dosimeter 
(Gy) 
Measured dose 
(Gy) 
Relative 
difference 
Average 
difference 
Standard de-
viation on 
differences 
13 mA 
25 10 
11.16 11.98 7.4%   
11.06 11.89 7.6% 6.5% 1.7% 
11.15 11.66 4.5%     
10 
2 
2.31 2.43 5.3%   
2.24 2.36 5.5% 5.3% 0.2% 
2.23 2.35 5.1%     
0.5 
0.49 0.52 6.2%   
0.48 0.52 8.8% 7.1% 1.5% 
0.48 0.51 6.4%     
5 
2 
2.27 2.41 6.3%   
2.23 2.36 5.6% 6.0% 0.4% 
2.35 2.49 6.2%     
0.5 
0.48 0.49 1.9%   
0.48 0.51 6.9% 5.6% 3.3% 
0.50 0.55 8.1%     
1.3 mA 
25 0.1 
0.10 0.10 1.8%   
0.11 0.11 5.0% 3.3% 1.6% 
0.10 0.11 3.2%     
10 
0.5 
0.61 0.61 -0.3%   
0.59 0.60 1.6% -0.7% 2.5% 
0.59 0.57 -3.3%     
0.1 
0.11 0.12 3.9%   
0.11 0.12 2.8% 3.7% 0.8% 
0.11 0.11 4.4%     
5 
0.5 
0.60 0.61 1.7%   
0.59 0.64 8.7% 4.2% 3.9% 
0.62 0.63 2.3%     
0.1 
0.11 0.11 -1.2%   
0.11 0.11 -0.3% 0.7% 2.6% 
0.11 0.12 3.7%     
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3.3. Rat brain irradiations 
Planned and measured doses obtained during post mortem and in vivo irradiations by an anterior beam 
are summarized in table 3. Post mortem reproducibility measurements (corresponding to the 5 and 
10 mm diameter irradiation fields) show larger standard deviations of the relative differences when the 
prescribed dose is low (0.1 and 0.5 Gy). On the contrary, the reproducibility does not seem to depend 
on the dose rate (tube current). In the case of in vivo measurements (25 mm diameter collimator), the 
standard deviations of the relative differences are comparable (1.70 and 1.56 %) for both delivered 
doses. It is explained by the variability between the different animals used for each measurement and 
the less accurate positioning of the detector in the irradiation field with the lasers. Finally, the relative 
differences between planned and measured doses range from -3.3 % to 8.8 % with an average value of 
4.2 % and a standard deviation of 3.0 %. 
4. Discussion 
The consistency between the planned and the measured dose obtained with the phantom (relative dis-
crepancies ranging from 0.5 to 4.0 %) is comparable to the TPS uncertainty and other dosimetry verifi-
cations performed on phantoms with micro-irradiators. Van Hoof et al23 obtained a good agreement 
between planned doses and doses measured with EBT2 films for a plasticized heterogeneous mouse 
phantom (PlastiMouse – SmART Scientific solution B.V.) irradiated by a single beam with a 5 mm 
diameter collimator. Except in the penumbra area, differences were smaller than 5 %. Noblet et al24 
compared Monte Carlo simulations performed with GATE25 and EBT3 film measurements for a water-
filled cylinder of 2.8 cm diameter irradiated by a 360°-arc with various collimators. The doses simulated 
and measured on the arc rotation axis presented discrepancies of -1.1 %, 2.1 % and 1.1 % for irradiation 
field diameters of 20 mm, 5 mm and 2.5 mm respectively. Nevertheless, the comparison between 
planned and measured dose is limited by the TPS uncertainty. It doesn’t allow to discriminate errors 
coming from the detector, the treatment planning or the delivery system. Additional investigations, such 
as comparison with other detectors in small fields, would thus allow to identify the different sources of 
error. 
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Concerning in vivo dosimetry, this work presents first measurements performed with a direct-reading 
point detector. The comparison with planned doses shows a satisfying agreement with relative discrep-
ancies ranging from -3.3% to 8.8 %. The relative differences obtained during post mortem irradiations 
also seem to show larger standard deviations for the lowest doses. This effect can’t be directly explained 
by the precision of the dosimeter as a function of the dose. Indeed Le Deroff et al16 showed an excellent 
repeatability of the dosimeter response at the treatment beam quality, without significant dependence 
with the measured dose. This observation should thus be confirmed and investigated in future experi-
ments. 
The deviations achieved in vivo are larger than the ones obtained with the phantom, which can have 
several explanations. Animal tissues compositions are not well known and human tissue compositions 
are used instead, 9 which can lead to dose calculation errors. Moreover, only three different tissues and 
materials were used in our study: soft tissues, bone and air. Bazalova et al26 and Noblet et al27 showed 
that the number of tissues used to compute the dose (skin, soft tissues, brain, grey matter, white matter, 
fat, bones of the skull) affects the result because of the important variability of the mass absorption 
coefficients between the different materials in this energy range. The second possible origin of these 
larger differences concerns DosiRat energy response correction factors, which were computed with  the 
PMMA phantom. The geometry of the animal head, the tissues composition and density can modify the 
energy spectrum and consequently induce a bias. This would be particularly true for intra-cavity or beam 
exit measurements. This observation raises the issue of computing individual correction factors to take 
into account morphological difference between animals. These factors rely on time-consuming Monte 
Carlo simulations (especially when they include CBCT images) which would inevitably prevent online 
monitoring of the delivered dose. It must be noted that this problem is relevant for any detector made 
from a material different from the reference materials (water or air) in kilovoltage dosimetry. 28 
Finally, the implementation of in vivo dosimetry at the animal scale is challenging. Besides energy var-
iations mentioned above, the positioning of the dosimeter in millimetric beams is difficult and lasers are 
not accurate enough. The smallest field that could be accurately controlled in this work was 5 mm di-
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ameter. This could be improved with a smaller scintillating probe. The dosimeter positioning reproduc-
ibility and the impact of positioning errors on dose reading should also be investigated to determine the 
reliability of the lasers depending on the beam size. When an accurate positioning can’t be achieved 
with the lasers, CBCT imaging allows sub-millimeter accuracy to align the dosimeter with the beam 
axis but attention must be given to the additional dose delivered during positioning imaging. Indeed, air 
kerma measurements and MC simulations showed that the CBCT acquisitions performed in this study 
deliver about 0.06 Gy to the phantom. This value is significant relative to planned doses of 0.1 Gy and 
should be considered during the interpretation of biological results. The imaging panel could also be 
used in conjunction with the irradiation collimator to quickly determine if the active volume of the 
scintillator is in the irradiation field, which should limit the imaging dose delivered to the animal. Two-
dimension detectors such as dosimetry films avoid this difficulty. Nevertheless, they are not adapted to 
control the beam position relative to the irradiation target, preventing the detection of positioning errors 
or motions during irradiation. 
5. Conclusion 
This work highlighted the complexity to implement in vivo dosimetry in orthovoltage millimetric beams. 
The plastic scintillating detector DosiRat is a suitable dosimeter that showed good results to answer this 
issue. In vivo measured dose showed discrepancies with planned doses smaller than 8.8 % for anterior 
beams down to 5 mm diameters. Despite the small size of DosiRat sensitive volume, the dosimetry of 
smaller beams is limited by the positioning of the detector on the beam axis. Thanks to its size and its 
direct reading, DosiRat has the potential to perform online dose monitoring. 
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